Umuthi omusha ojwayelekile we-schizophrenia, ukucindezeleka kanye ne-bipolar disorder

I-Pharmascience Canada yethule umuthi wayo omusha ojwayelekile i-pms-LURASIDONE emakethe yaseCanada futhi uzotholakala ngezindleko eziphansi ezigulini. 

I-Pms-LURASIDONE ikhonjiswa njenge-monotherapy yokuphatha ukubonakaliswa kwe-schizophrenia kubantu abadala nasebusheni (iminyaka engu-15-17 ubudala). Kuboniswa futhi ekuphathweni okunamandla kweziqephu ezicindezelayo ezihambisana ne-bipolar disorder kubantu abadala kanye nentsha (iminyaka engu-13-17 ubudala). Yize i-pms-LURASIDONE ingeke izelapha lezi zinkinga, ingasiza ukuphatha izimpawu.

Lo mkhiqizo, ongeleqembu lemithi ebizwa ngokuthi i-atypical antipsychotics, uzosatshalaliswa ngamandla amaningana, afana no-20 mg, 40 mg, 60 mg, 80 mg kanye no-120 mg.

Inikeza iphrofayela efanayo yokuphepha nokusebenza ngempumelelo njengomkhiqizo wegama lomkhiqizo, lawa maphilisi e-pms-LURASIDONE ayi-generic bioequivalent ne-Latuda ®.